BC Week In Review | Sep 20, 1999
Clinical News

AneuVysion Assay: Marketed

Researchers published in Fetal Diagnosis and Therapy data from 3,280 women with high-risk pregnancies presenting an abnormal ultrasound or serum screening results or at least 35 years old. AneuVysion produced an analysis of all detectable...
BioCentury | Sep 20, 1999

London dresses up high-tech

In an attempt to increase investor interest, the London Stock Exchange has devised a new mechanism to plug its high technology and biotechnology companies. Beginning in November, companies on the main exchange list falling under...
Items per page:
1 - 2 of 2